Image Credit: STAT News
STAT+: Investors in Padlock Therapeutics sue Bristol Myers Squibb over ‘milestone’ payments
Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated as part of a 2016 acquisition agreement.